Actarit

Actarit
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	None;
Identifiers
	IUPAC name (4-Acetamidophenyl)acetic acid;
CAS Number	18699-02-0 ;
PubChem CID	2018;
ChemSpider	1941 ;
UNII	HW5B6351RZ;
KEGG	D01395 ;
ChEMBL	ChEMBL1226203 ;
CompTox Dashboard (EPA)	DTXSID0020020 ;
ECHA InfoCard	100.038.631
Chemical and physical data
Formula	C10H11NO3
Molar mass	193.202 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)Cc1ccc(cc1)NC(=O)C;
	InChI InChI=1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14) ; Key:MROJXXOCABQVEF-UHFFFAOYSA-N ;
	(what is this?) (verify)

Actarit is a disease-modifying antirheumatic drug (DMARD) developed in Japan for use in rheumatoid arthritis.^[1]

References

^ Takeba Y, Suzuki N, Wakisaka S, Nagafuchi H, Mihara S, Kaneko A, et al. (January 1999). "Effects of actarit on synovial cell functions in patients with rheumatoid arthritis". The Journal of Rheumatology. 26 (1): 25–33. PMID 9918236.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.